All In Biotech

Drug Trial Radar · NCT07006792

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

A Phase 4, Multicenter, Open-label, Single-arm Study to Investigate the Efficacy of Lebrikizumab in Adult and Adolescent Participants With Moderate Atopic Dermatitis and High Itch Burden

Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

233

Actual

Start

Jun 16, 2025

Primary completion

May 14, 2026

Study completion Sep 21, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Jun 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy. Participation in this study will last up to approximately 38 weeks (9 and a half months) including 24 weeks (6 months) of treatment.

Conditions

  • Atopic Dermatitis

Interventions

  • LebrikizumabDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Achieving Eczema Area and Severity Index-75 (EASI-75) (≥75% Reduction from Baseline in EASI), or a ≥4-point Reduction in Pruritus Numerical Rating Scale (NRS) from BaselineTime frame: Week 16

Locations

66 sites in 5 countries. Site status is shown where the registry gives one.

  • Total Skin & Beauty Dermatology Center, PC DBA Total Dermatology

    Birmingham, Alabama

  • Research Solutions of Arizona

    Litchfield Park, Arizona

  • Alliance Dermatology and Mohs Center

    Phoenix, Arizona

  • California Dermatology & Clinical Research Institute

    Encinitas, California

  • Dermatology Research Associates

    Los Angeles, California

  • NorCal Clinical Research

    Rocklin, California

  • Suncoast Research Associates

    Doral, Florida

  • Encore Medical Research

    Hollywood, Florida

  • Solutions Through Advanced Research

    Jacksonville, Florida

  • Life Arc Research Centers - Miami

    Miami, Florida

  • MCR Research

    Miami, Florida

  • Health Clinical Research

    Miami, Florida

  • Deluxe Health Center

    Miami Lakes, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Leading Edge Dermatology

    Plantation, Florida

  • Dermatology Affiliates Research Institute

    Atlanta, Georgia

  • DeNova Research

    Chicago, Illinois

  • Southern Indiana Clinical Research Center

    Columbus, Indiana

  • Dawes Fretzin Clinical Research Group, LLC

    Indianapolis, Indiana

  • Southern Indiana Clinical Trials

    New Albany, Indiana

  • Equity Medical - Bowling Green

    Bowling Green, Kentucky

  • Allergy & Asthma Specialists, P.S.C.

    Owensboro, Kentucky

  • Foxhall Research Center

    Chevy Chase, Maryland

  • Great Lakes Research Group, Inc.

    Bay City, Michigan

  • Revival Research Institute, LLC

    Troy, Michigan

  • Albuquerque Clinical Trials, Inc.

    Albuquerque, New Mexico

  • Equity Medical

    New York, New York

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • Hickory Dermatology Research Center

    Hickory, North Carolina

  • ObjectiveHealth - Goodlettsville Dermatology Research

    Goodlettsville, Tennessee

  • Reveal Research Institute - Frisco

    Frisco, Texas

  • Biopharma Informatic, LLC

    Houston, Texas

  • Prime Clinical Research - Mansfield

    Mansfield, Texas

  • Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue

    San Antonio, Texas

  • Jordan Valley Dermatology & Research Center

    South Jordan, Utah

  • CONEXA Investigacion Clinica S.A.

    Buenos Aires, Argentina

  • CIPREC

    Buenos Aires, Argentina

  • Centro de Investigaciones Metabólicas (CINME)

    Buenos Aires, Argentina

  • DOM Centro de Reumatología

    Buenos Aires, Argentina

  • Instituto de Neumonologia Y Dermatologia

    Buenos Aires, Argentina

Showing 40 of 66 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.